Abstract: Eccrine poromas and porocarcinomas are adnexal tumors derived from the sweat duct epithelium. However, eccrine poroma is benign in nature, whilst eccrine porocarcinoma is regarded as its malignant counterpart. We report the case of a man who presented simultaneously with an eccrine poroma and eccrine porocarcinoma. Both lesions had no clear distinctive features, enhancing the need of high-level clinical suspicion together with surgical excision and histopathology for prompt diagnosis confirmation.
INTRODUCTION
Eccrine poroma (EP) is a benign adnexal tumor derived from the intra-epidermal sweat duct epithelium. Eccrine porocarcinoma (EPC), instead, is regarded as the malignant counterpart of EP.
Herein we report the case of a man who presented simultaneously with an EP and an EPC.
CASE REPORT
We report a 74-year-old male patient who presented with a 4-year history of two skin lesions with progressive growth. Physical examination showed a 0.5-cm, dome shaped, well-circumscribed erythematous-to-violaceous nodule on the chest, and a 1.5-cm, irregular and lobulated-shaped tumor on the back (Figures 1 and 2 ). We performed a surgical excision of both lesions and reached the histopathological diagnosis of EP on the chest and EPC on the back (Figures 3 and 4) .
DISCUSSION
EP is a benign adnexal neoplasm, whose clinical appearance is that of a pink to red, solitary nodule, papule, or plaque. EPC can be observed as an erythematous-to-violaceous nodule, papule, plaque, or tumor, arising most often on lower extremities, followed by the head. 3 The differential diagnosis includes basal and squamous cell carcinoma, pyogenic granuloma, verruca vulgaris, adenocarcinoma, and amelanotic, pigmented, or desmoplastic nodular variants of melanoma. 5 The diagnosis of EPC is difficult. Luz et al. analyzed 8 cases of EPC and found that, even after the initial biopsy (performed in primary care clinics by non-expert histopathologists), half of the patients had an inaccurate diagnosis with a mean time of 36 months until definitive treatment by a cancer center. 6 Sudden clinical changes -such as sudden growth, ulceration, and spontaneous bleeding in a longstanding stable lesionsuggest malignant degeneration.
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Dermoscopy does not help the diagnosis, as both EP and EPC can present with polymorphous vessels. Histopathologic criteria, instead, are useful to differentiate both entities. Some features are indicative of EPC: atypical poroid cells with pleomorphic nuclei, increased nuclear-cytoplasmic ratio, high atypical mitotic activity rate, ductal differentiation, and ill-defined or infiltrating borders. 7 This latter is considered the most important feature to differentiate between malignant and benign tumors, as cellular atypia can also occur in benign poromas.
EPC is potentially fatal. The incidence of metastasis to lymph nodes is 20%, whilst to viscera is 10%. Risk factors for nodal metastasis include the presence of more than 14 mitosis per high-power field, a Breslow index of more than 7 mm, and lymphovascular invasion. 6, 8 The role of sentinel lymph node is doubtful in these cases. 9 Surgical excision with histologically clear margins is the optimal management for EP undergoing recent changes, as an incisional biopsy may appear falsely benign. 7 In early EPC lesions, cure is possible in up to 70-80% of patients, although a high recurrence rate of up to 20% has been reported. 10 For patients with metastasis, there is no adjuvant therapy with strong evidence for the management of this tumor.
Since EPC is a rare tumor with morphological particularities and similarities to other carcinomas, its diagnosis is challenging.
We describe the case of a patient with an EP and an EPC simulta- 
